Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Antiviral therapy reduced the need for hospitalization and emergency treatment for liver-related and other conditions.
A four-drug combination cured all individuals who had experienced prior treatment failure.
People treated for HCV were cured even without direct intervention from a specialist.
People who received a shortened course of antiviral therapy were less likely to be cured.
People under 50 who were cured of hepatitis C were at comparable risk to the general population.
However, some 10% experienced liver decompensation even after antiviral therapy.
Based on surveys conducted in 2015 and 2018, the number appears to have nearly tripled in San Francisco.
The risk was lower in people who had achieved a sustained virological response compared with those who had not.
Regardless of cirrhosis status, Mavyret led to high sustained virologic response rates in Latinos and other groups with hep C.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.